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Abstract
The diagnosis of cerebral relapse of Whipple’s disease in a 67-
year-old patient was made after he presented with
somnolence and severe hypothermia 4 months after
discontinuing treatment with cotrimoxazole. Hypothermia is a
rare hypothalamic manifestation of cerebral Whipple’s disease.
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Introduction
Whipple’s disease (WD) is a systemic disorder that includes
neurologic involvement in 15% of cases [1]. Its causative
agent is Tropheryma whipplei [2]. Diagnosis can be con-
firmed by periodic acid-Schiff (PAS)-positive inclusions in
macrophages or PCR analysis in duodenal mucosa or cere-
brospinal fluid.
Case Report
We describe a patient who presented with unexplained weight loss,
diarrhea and hypoalbuminemia at the age of 63. He had been suf-
fering from myalgias of the proximal limbs for 7 years and was
treated with up to 60 mg prednisone daily because of suspected
polymyalgia rheumatica. The diagnosis of WD was made by PAS
stain positive macrophages in a duodenal biopsy specimen.Treat-
ment with cotrimoxazole 160/800 mg twice daily was started. The
patient’s condition improved and duodenal biopsies over the next
years showed regression of WD without complete clearance. Pred-
nisone could not be reduced below 7.5 mg daily due to relapsing
myalgias.At the age of 67 the patient presented with memory dis-
orders to a neurologist. Four months earlier he had stopped cotri-
moxazole treatment. Clinical examination and a CT scan showed
no significant abnormalities. On the basis of an EEG, complex par-
tial seizures were suspected and treatment with carbamazepin
200 mg daily was started. One month later the patient was admit-
ted to our hospital with unexplained somnolence after a car acci-
dent. On admission blood pressure was 130/90 mmHg; heart rate,
52 per min and core temperature, 33.2 °C. Neurological examina-
tion showed somnolence, mutism and a slight spastic tetraparesis
with a bilaterally positive  Babinski’s sign. An MRI revealed mul-
tiple punctuate and confluent lesions of increased signal intensity
affecting the hypothalamus, fornix and the periventricular
subependymal grey and white matter in a symmetric fashion (Fig-
ure 1 A). The lesions predominantly extended along the frontal
horns within the caudate nucleus and along the third ventricle.
Cerebral involvement of WD was proved by phagocytic cells in
the cerebrospinal fluid with typical PAS-positive inclusions (Fig-
ure 1 B) and positive PCR for T. whipplei. Treatment with cotri-
moxazole 160/800 mg twice daily and rifampicin 300 mg three
times daily was started. The patient’s condition improved and he
was able to handle everyday activities. Hypothermia with a core
temperature ranging between 31.1 and 35.4 °C (mean: 33.3 °C)
persisted for 9 weeks.
The following febrile episode was attributed to catheter sep-
sis. Several syncopes occurred and echocardiography confirmed
severe aortic stenosis with calcification.The patient developed hy-
potension and pulmonary edema. He was treated with vasoactive
drugs and antibiotics including vancomycin 1 g, netromycin
300 mg, rifampicin 900 mg and ceftriaxone 2 g daily. Blood cultures
remained negative. He died in refractory shock despite aortic
valvuloplasty performed 2 weeks earlier. Autopsy of the heart re-
vealed no signs of endocarditis. The brain autopsy showed cere-
bral involvement of WD macroscopically, by histological exami-
nation (Figures 1 C, 1 D) and by electron microscopy.
Discussion
The patient described suffered from gastrointestinal WD
preceded by myalgia for 7 years before the diagnosis of WD
was made.The clinical presentation of myalgia and arthral-
gia is well known in WD and precedes the diagnosis by a
mean of 6.7 years [3]. Prednisone was not reduced below
7.5 mg daily because of relapsing symptoms. It remains un-
clear if these symptoms were due to WD or a second dis-
order such as polymyalgia rheumatica.
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At the age of 67 the patient presented with a cerebral
relapse of WD with cognitive changes and persistent hy-
pothermia. Treatment had been stopped for 5 months when
the first signs of cerebral involvement appeared.
The diagnosis of cerebral WD remains a problem, even
though neurologic symptoms occur in 15% of cases [1]. It
has been shown that CNS involvement diagnosed by PAS-
positive cells in the cerebrospinal fluid examination are
common in patients with WD without neurological symp-
toms [4]. In our patient further symptoms included seizures,
somnolence and severe hypothermia. A review of 84 cases
of cerebral WD showed that cognitive changes and altered
levels of consciousness are frequent and occur in 71% and
50% of patients with cerebral manifestations, respectively
[5]. In this series hypothermia was not  described as a hy-
pothalamic manifestation of WD. It had been described pre-
viously but is very rare [6, 7].A propensity for cerebral man-
ifestations of WD to affect midline structures has previously
been described by MRI, including signal intensity changes
in the hypothalamus [8]. Off midline lesions were observed
to affect the subcortical white matter, and did not take up
contrast nor exhibit space-occupying effects [9].The radio-
logic findings in this patient are in agreement with the lit-
erature with respect to their central location. However, the
nodular subependymal extension, the striking symmetry
and the lack of subcortical white matter involvement differ
from previous reports.
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Figure 1. A. Coronal T1 weighted MRI showed nodular hypothalamic and periventricular contrast enhancement extending into the adjacent
subependymal grey matter and along the floor of the third ventricle and fornix. B. Cerebrospinal fluid examination showed phagocytic cells
with PAS-positive inclusions. C. Frontal sections of the formalin fixed brain revealed multiple lesions surrounded by a bright rim. They were
mainly distributed along the wall of the lateral ventricles but were also found in the hypothalamus. D. Histological examination of the paraffin
embedded sections revealed numerous plaque-like and PAS-positive deposits. Closely associated with these plaques were macrophages filled
with small PAS-positive particles.
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